Kenneth E Morgenstern
- Botulinum toxin type a for dysthyroid upper eyelid retractionK E Morgenstern
Grant Eye and Ear Hospital, The Ohio State University, Columbus, Ohio, USA
Ophthal Plast Reconstr Surg 20:181-5. 2004..To evaluate the safety and efficacy of botulinum toxin type A for treatment of eyelid retraction resulting from thyroid eye disease (TED) during the inflammatory phase of the condition...
- Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patientsKenneth E Morgenstern
Department of Ophthalmology, Division of Oculoplastic Surgery, The Ohio State University, Columbus, OH, USA
Ophthal Plast Reconstr Surg 21:337-44. 2005..We hypothesized that NIS is expressed in the lacrimal sac and nasolacrimal duct and that active accumulation of I(131) is responsible for the clinical observations seen in these patients...
- Fibrin sealant for Müller muscle-conjunctiva resection ptosis repairJill A Foster
The Ohio State University, Columbus, USA
Ophthal Plast Reconstr Surg 22:184-7. 2006..To determine the safety and efficacy of fibrin sealant for use in Müller muscle-conjunctiva resection ptosis repair...
- Pediatric canaliculitis and stone formationAnna Park
Ohio State University, Department of Ophthalmology, Division of Oculoplastic Surgery, Columbus, Ohio, USA
Ophthal Plast Reconstr Surg 20:243-6. 2004..Although the diagnosis is uncommon in this age group, it should be included in the differential diagnosis of chronic or recurrent pediatric nasolacrimal obstruction...